Analystreport

Theravance Biopharma (TBPH) had its price target raised by B. Riley Financial, Inc. from $14.00 to $17.00. They now have a "neutral" rating on the stock.

Theravance Biopharma, Inc. - Ordinary Shares  (TBPH) 
Last theravance biopharma, inc. - ordinary shares earnings: 2/24 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.theravance.com/investor-relations